Premium
GT Biopharma Inc (GTBP)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms. It develops GTB-3650, which is in phase 1 ... GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms. It develops GTB-3650, which is in phase 1 trials that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550, that is in phase 1 dose escalation basket trial that targets B7-H3 on the surface of advanced solid tumors;and GTB-7550, a pre-clinical stage product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0472 | -10.102739726 | 0.4672 | 0.48 | 0.403 | 1245738 | 0.44221312 | CS |
| 4 | 0.1032 | 32.5757575758 | 0.3168 | 0.495 | 0.31 | 2576833 | 0.43296943 | CS |
| 12 | -0.01 | -2.32558139535 | 0.43 | 0.495 | 0.261 | 1301963 | 0.41524052 | CS |
| 26 | -0.23 | -35.3846153846 | 0.65 | 0.944 | 0.261 | 1407226 | 0.55148701 | CS |
| 52 | -2.83 | -87.0769230769 | 3.25 | 3.85 | 0.261 | 1259422 | 0.73659668 | CS |
| 156 | 0.07 | 20 | 0.35 | 10.6599 | 0.1708 | 675930 | 2.02609942 | CS |
| 260 | -17.87 | -97.7036632039 | 18.29 | 19.7331 | 0.1708 | 485289 | 2.50955045 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
